| 000 | 01021 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517200818.0 | ||
| 264 | 0 | _c20190329 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a2212-4063 | ||
| 024 | 7 |
_a10.2174/1871529X18666180206161457 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFulmer, Makenzie L | |
| 245 | 0 | 0 |
_aThe Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2. _h[electronic resource] |
| 260 |
_bCardiovascular & hematological disorders drug targets _c2018 |
||
| 300 |
_a34-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aEndocannabinoids _xgenetics |
| 650 | 0 | 4 |
_aHeart Diseases _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aThewke, Douglas P | |
| 773 | 0 |
_tCardiovascular & hematological disorders drug targets _gvol. 18 _gno. 1 _gp. 34-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871529X18666180206161457 _zAvailable from publisher's website |
| 999 |
_c28055364 _d28055364 |
||